These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7755955)

  • 1. Hyperinsulinemia and hypertension. Do intestinal hormones play a role?
    Tedde R; Pala A; Melis A; Sechi G; Bilotta F; Realdi G
    Am J Hypertens; 1995 Feb; 8(2):99-103. PubMed ID: 7755955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and urinary excretion of sodium in hypertensive patients with non-insulin dependent diabetes mellitus.
    Singh SK; Sarkar D; Agrawal JK
    J Assoc Physicians India; 1999 Jul; 47(7):709-11. PubMed ID: 10778592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
    Osei K; Falko JM; O'Dorisio TM; Fields PG; Bossetti B
    J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans.
    Meier JJ; Goetze O; Anstipp J; Hagemann D; Holst JJ; Schmidt WE; Gallwitz B; Nauck MA
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E621-5. PubMed ID: 14678954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
    Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M
    Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
    Jarmuzewska EA; Ghidoni A
    Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glucose-dependent insulinotropic polypeptide (GIP) on insulin response to glucose in acromegalics.
    Pierluissi J; de Pierluissi RM
    Acta Cient Venez; 1995; 46(2):89-96. PubMed ID: 9279024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes.
    Irwin N; McClean PL; Patterson S; Hunter K; Flatt PR
    Biol Chem; 2009 Jan; 390(1):75-80. PubMed ID: 18937625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between blood pressure and serum insulin response in glucose intolerant subjects.
    Ansari AJ; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):55-63. PubMed ID: 8815863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholinergic stimulation and antagonism on plasma insulin concentration in lean and obese human subjects.
    Tappy L; Chiolero R; Randin JP; Burckhardt P; Felber JP
    Horm Metab Res; 1986 Dec; 18(12):821-6. PubMed ID: 3546047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.
    Ebert R; Creutzfeldt W
    Acta Diabetol Lat; 1989; 26(1):1-15. PubMed ID: 2665406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gastric inhibitory polypeptide in postprandial hyperinsulinemia of obesity.
    Roust LR; Stesin M; Go VL; O'Brien PC; Rizza RA; Service FJ
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E767-74. PubMed ID: 3287953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats.
    Bryer-Ash M; Cheung A; Pederson RA
    Regul Pept; 1994 May; 51(2):101-9. PubMed ID: 8059006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of body weight, age and glucose tolerance on the relationship between GIP secretion and beta-cell function in man.
    Groop PH
    Scand J Clin Lab Invest; 1989 Jun; 49(4):367-79. PubMed ID: 2662384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.